期刊文献+

Comparative Study on the Immunogenicity between Recombinant MS-Sj26GST Vaccine and Recombinant BCG-Sj26GST Vaccine in Schistosoma japonicum

Comparative Study on the Immunogenicity between Recombinant MS-Sj26GST Vaccine and Recombinant BCG-Sj26GST Vaccine in Schistosoma japonicum
下载PDF
导出
摘要 The BALB/c mice were immunized with rMS Sj26GST and rBCG Sj26GST vaccine in Schistosoma japonicum by subcutaneous injection After they were immunized for 8 weeks, the eyeballs were removed to get blood and macrophages of abdominal cavity and spleen cells were harvested The lymphocytic stimulating index (SI) was used to measure the cellular proliferating ability and NO release was used to measure the phagocytic activity of the macrophages By using ELISA kit, the levels of interleukin 2 (IL 2) and interferon γ (IFN γ) in serum and the splenic lymphocytic cultured supernatant were detected The results showed that after the mice were immunized with 10 6 CFU of rMS Sj26GST and rBCG Sj26GST vaccine separately by subcutaneous injection, proliferating ability of splenic lymphocytes in the mice showed no difference ( P >0 05), but both were significantly increased as compared with that in the control group( P <0 05); The contents of NO in the intraperitoneal macrophages of rMS Sj26GST vaccine group were significantly lower than in the control group ( P <0 001) and rBCG Sj26GST vaccine group ( P <0 01); The levels of serum IL 2 in the rMS Sj26GST vaccine group were significantly increased as compared with that in the control group ( P <0 001), vector group ( P <0 01) and rBCG Sj26GST vaccine group ( P <0 05); The contents of serum IFN γ in the rMS Sj26GST vaccine group were significantly increased as compared with that in the control group ( P <0 01) and rBCG Sj26GST vaccine group ( P <0 05) The contents of IFN γ in the cultured supernatant were significantly lower than those of rBCG Sj26GST vaccine group ( P <0 001), but were significantly increased as compared with that in the control group ( P <0 01) It was indicated that both vaccines could enhance the immune response of the mice, but rMS Sj26GST vaccine had stronger immunogenicity than rBCG Sj26GST vaccine The BALB/c mice were immunized with rMS Sj26GST and rBCG Sj26GST vaccine in Schistosoma japonicum by subcutaneous injection After they were immunized for 8 weeks, the eyeballs were removed to get blood and macrophages of abdominal cavity and spleen cells were harvested The lymphocytic stimulating index (SI) was used to measure the cellular proliferating ability and NO release was used to measure the phagocytic activity of the macrophages By using ELISA kit, the levels of interleukin 2 (IL 2) and interferon γ (IFN γ) in serum and the splenic lymphocytic cultured supernatant were detected The results showed that after the mice were immunized with 10 6 CFU of rMS Sj26GST and rBCG Sj26GST vaccine separately by subcutaneous injection, proliferating ability of splenic lymphocytes in the mice showed no difference ( P >0 05), but both were significantly increased as compared with that in the control group( P <0 05); The contents of NO in the intraperitoneal macrophages of rMS Sj26GST vaccine group were significantly lower than in the control group ( P <0 001) and rBCG Sj26GST vaccine group ( P <0 01); The levels of serum IL 2 in the rMS Sj26GST vaccine group were significantly increased as compared with that in the control group ( P <0 001), vector group ( P <0 01) and rBCG Sj26GST vaccine group ( P <0 05); The contents of serum IFN γ in the rMS Sj26GST vaccine group were significantly increased as compared with that in the control group ( P <0 01) and rBCG Sj26GST vaccine group ( P <0 05) The contents of IFN γ in the cultured supernatant were significantly lower than those of rBCG Sj26GST vaccine group ( P <0 001), but were significantly increased as compared with that in the control group ( P <0 01) It was indicated that both vaccines could enhance the immune response of the mice, but rMS Sj26GST vaccine had stronger immunogenicity than rBCG Sj26GST vaccine
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2003年第3期213-215,218,共4页 华中科技大学学报(医学英德文版)
基金 ThisprojectwassupportedbyagrantfromNationalNaturalSciencesFoundationofChina (No 39870 6 6 3)
关键词 Schistosoma japonnicum Mycobacterium smegmatis mc 2155(MS) BCG VACCINE IMMUNOGENICITY Schistosoma japonnicum Mycobacterium smegmatis mc 2155(MS) BCG Vaccine Immunogenicity
  • 相关文献

参考文献8

  • 1戴五星,皇甫永穆,郑波,程继忠,黄翠华,黄海浪.血吸虫重组卡介苗-Sj26GST疫苗的构建及免疫原性的研究[J].中华医学杂志,2000,80(6):407-410. 被引量:6
  • 2程继忠,皇甫永穆,海涛.外源基因在耻垢分枝杆菌中表达效率的研究[J].生物化学与生物物理进展,1997,24(3):249-253. 被引量:5
  • 3Sambrook J;Fritsch E F;Mantiatis T.Molecular Cloning, a Laboratory Mannual,1987.
  • 4Jankovic D;Wynn T A;Kullberg M C.Optimal vaccination against Schistosoma mansoni requires the induction of both B cell and IFN-gamma dependent effector mechanisms[J],1999(1).
  • 5YANG J;Mitsuyama M.An essential role for endogenous interferon-γ inthe generation of protective T cells against Mycobacterium bovis BCG in mice[J],1997.
  • 6Chang R H;Linfeng M H;Liu W H.Nitric oxide increased interleukin-4 expression in T lymphocytes[J],1997.
  • 7Aggard E.Nitric oxide: mediator, murderer and medicine[J],1994.
  • 8Invitro control of Mycobacterium bovis by macrophages[J],2001(1-2).

二级参考文献6

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部